The Column Group is a venture capital firm dedicated to developing biotechnology companies. TCG deploys an edge-to-edge investment model, harnessing an ecosystem of funds that propel early technology platforms, single assets and later-stage programs forward from inception through exit.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions